Radwan H M, Abdel-Shafeek K A. Phytochemical and bioactivity investigation of Chrysanthemum coronarium (var. discolor) during growing in Egypt [J]. Egypt J Pharmaceut, 2006, 47: 59.
[2]
Shafaghat A, Sadeghi H, Oji K. Composition and antibacterial activity of essential oils from leaf, stem and root of Chrysanthemum parthenium (L.) Bernh. from Iran [J]. Nat Prod Commun, 2009, 4: 859.
[3]
Shao Q S, Guo Q S, Deng Y M, et al. A comparative analysis of genetic diversity in medicinal Chrysanthemum morifolium based on morphology, ISSR and SRAP markers [J]. Biochem Syst Ecol, 2010, 38(6): 1160.
Jin M, Zhu Z B, Guo Q S, et al. Growth and accumulation of bioactive compounds in medicinal Chrysanthemum morifolium Ramat.cv.‘Chuju’ under different colored shade polyethylene [J]. J Med Plants Res, 2012, 6(3): 398.
Wang T, Zhu Z B, Guo Q S, et al. Variation in major flavonoids glycosides and caffeoylquinic acids during florescence of three Chrysanthemum morifolium Ramat cv. ‘Hangju’ genotypes[J]. Biochem Syst Ecol, 2013, 47:74.
[9]
Wang T, Guo Q S, Mao P F. Flavonoid accumulation during florescence in three Chrysanthemum morifolium Ramat cv. ‘Hangju’ genotypes[J]. Biochem Syst Ecol, 2014, 55:79.
Huang L Q, Guo L P, Ma C Y. Top-geoherbs of traditional Chinese medicine: common traits, quality characteristics and formation [J]. Front Med, 2011, 5(2): 185.
[13]
中国药典.一部[S].2010:292.
[14]
Teixeira da Silva J A. Chrysanthemum: advances in tissue culture, cryopreservation, postharvest technology, genetics and transgenic biotechnology[J]. Biotechnol Adv, 2003, 21(8): 715.
[15]
Liu D H, Liu W, Zhu D W, et al. Nitrogen effects on total flavonoids, chlorogenic acid, and antioxidant activity of the medicinal plant Chrysanthemum morifolium [J]. J Plant Nutr Soil Sci, 2010, 173(2): 268.
[16]
Lin L Z, Harnly J M. Identification of the phenolic components of chrysanthemum flower (Chrysanthemum morifolium Ramat) [J]. Food Chem, 2010, 120(1): 319.
[17]
Lee J S, Kim H J, Lee Y S, et al. A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium [J]. Planta Med, 2003, 69(9): 859.
[18]
Kima I S, Koppulaa S, Parka P J, et al. Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity [J].J Ethnopharmacol, 2009, 126(3): 447.
[19]
Tsuji-Naito K, Saeki H, Hamano M. Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products [J]. Food Chem, 2009, 116(4): 854.
[20]
Lii C K, Lei Y P, Yao H T, et al. Chrysanthemum morifolium Ramat. reduces the oxidized LDL-induced expression of intercellular adhesion molecule-1 and E-selectin in human umbilical vein endothelial cells [J]. J Ethnopharmacol, 2010, 128(1): 213.
[21]
Lai J P, Lim Y H, Su J, et al. Identification and characterization of major flavonoids and caffeoylquinic acids in three Compositae plants by LC/DAD-APCI/MS [J]. J Chramatogr B, 2007, 848(2): 215.
[22]
Wilkomirski B, Dubielecka B. Sterol content as a similarity marker of different organs of two varietas of Chrysanthemum parthenium[J]. Phytochemistry, 1996, 42(6): 1603.
[23]
Gins V K, Kolesnikov M P, Kononkov P F. Hydroxyanthraquinones and flavonoids of garland chrysanthemum[J]. Appl Biochem Microbiol, 2000, 3: 296.
